|
Index of reports
> Cases resulting in death (16)
Below is the selection of adverse event reports related to Zetia (Ezetimibe) that includes cases resulting in death.
Adverse event in female receiving Zetia (Ezetimibe)
Reported by a physician from Canada on 2007-07-18
Patient: female
Adverse reactions / side effects: Death
Adverse event resulted in: death
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Statin (Unspecified)
Adverse event in male receiving Zetia (Ezetimibe)
Reported by a consumer/non-health professional from United States on 2007-07-09
Patient: male
Adverse reactions / side effects: Completed Suicide
Adverse event resulted in: death
Suspect drug(s):
Zetia (Ezetimibe)
Adverse event in 41 year old male receiving Zetia (Ezetimibe)
Reported by a health professional (non-physician/pharmacist) from Finland on 2007-06-29
Patient: 41 year old male
Adverse reactions / side effects: Sudden Death
Adverse event resulted in: death
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Crestor; Crestor
Adverse event in 56 year old male receiving Zetia (Ezetimibe)
Reported by a health professional (non-physician/pharmacist) from France on 2007-06-28
Patient: 56 year old male, weighing 80.0 kg (176.0 pounds)
Adverse reactions / side effects: Cardiac Arrest
Adverse event resulted in: death
Suspect drug(s):
Crestor
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2005-06-02
End date: 2005-06-27
Zetia
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2005-06-07
End date: 2005-06-27
Other drugs received by patient: Coversyl (Perindopril Erbumine); Tenormin; Adalat; Plavix
Adverse event in 50 year old male receiving Zetia (Ezetimibe)
Reported by a physician from Australia on 2007-06-22
Patient: 50 year old male, weighing 80.0 kg (176.0 pounds)
Adverse reactions / side effects: Ischaemia, Hepatitis Acute, Anaemia, Cardiac Output Decreased, Hepatic Enzyme Increased, Death, Renal Failure, Hepatomegaly, Chronic Hepatic Failure
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Coversyl (Perindopril Erbumine)
Administration route: Oral
Start date: 2004-08-19
Lasix
Indication: Ischaemia
Start date: 2003-01-01
Lasix
Indication: Left Ventricular Failure
Start date: 2003-01-01
Lipitor
Administration route: Oral
Start date: 2003-01-01
End date: 2004-09-27
Zetia
Administration route: Oral
Indication: Hypertension
Start date: 2004-08-01
End date: 2004-09-27
Zetia
Administration route: Oral
Indication: Coronary Artery Disease
Start date: 2004-08-01
End date: 2004-09-27
Other drugs received by patient: Clopidogrel Bisulfate; Carvedilol; [composition Unspecified]
Adverse event in 79 year old male receiving Zetia (Ezetimibe)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-06-19
Patient: 79 year old male
Adverse reactions / side effects: Myocardial Infarction
Adverse event resulted in: death
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Beclomethasone Dipropionate; Bisoprolol Fumarate; Cozaar; Acetaminophen; Prazosin; Albuterol; Salmeterol
Adverse event in 50 year old male receiving Zetia (Ezetimibe)
Reported by a physician from Australia on 2007-06-13
Patient: 50 year old male, weighing 80.0 kg (176.0 pounds)
Adverse reactions / side effects: Ischaemia, Hepatitis Acute, Anaemia, Cardiac Output Decreased, Cardiac Disorder, Hepatic Enzyme Increased, Death, Renal Failure, Hepatomegaly, Chronic Hepatic Failure
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Coversyl (Perindopril Erbumine)
Administration route: Oral
Start date: 2004-08-19
Lasix
Indication: Ischaemia
Start date: 2003-01-01
Lasix
Indication: Left Ventricular Failure
Start date: 2003-01-01
Lipitor
Administration route: Oral
Start date: 2003-01-01
End date: 2004-09-27
Zetia
Administration route: Oral
Indication: Hypertension
Start date: 2004-08-01
End date: 2004-09-27
Zetia
Administration route: Oral
Indication: Coronary Artery Disease
Start date: 2004-08-01
End date: 2004-09-27
Other drugs received by patient: Clopidogrel Bisulfate; Carvedilol; [composition Unspecified]
Adverse event in male receiving Zetia (Ezetimibe)
Reported by a physician from Australia on 2007-06-07
Patient: male
Adverse reactions / side effects: Death, Chronic Hepatic Failure, Cardiac Disorder
Adverse event resulted in: death
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Simvastatin
Adverse event in 52 year old female receiving Zetia (Ezetimibe)
Reported by a physician from Netherlands on 2007-06-01
Patient: 52 year old female
Adverse reactions / side effects: Vanishing Bile Duct Syndrome, Biliary Fibrosis, Cholestasis, Hepatic Cirrhosis, Infection
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Atorvastatin Calcium
Adverse event in female receiving Zetia (Ezetimibe)
Reported by a individual with unspecified qualification from Canada on 2007-04-19
Patient: female
Adverse reactions / side effects: Death
Adverse event resulted in: death
Suspect drug(s):
Zetia (Ezetimibe)
Adverse event in male receiving Zetia (Ezetimibe)
Reported by a physician from Australia on 2007-04-02
Patient: male
Adverse reactions / side effects: Death, Chronic Hepatic Failure, Cardiac Disorder
Adverse event resulted in: death
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Zocor
Adverse event in 52 year old female receiving Zetia (Ezetimibe)
Reported by a physician from Netherlands on 2007-03-26
Patient: 52 year old female
Adverse reactions / side effects: Vanishing Bile Duct Syndrome, Hepatic Cirrhosis, Infection
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Atorvastatin Calcium
Adverse event in female receiving Zetia (Ezetimibe)
Reported by a physician from Netherlands on 2007-03-20
Patient: female
Adverse reactions / side effects: Death, Liver Disorder
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Zetia (Ezetimibe)
Adverse event in 67 year old female receiving Zetia (Ezetimibe)
Reported by a physician from Canada on 2007-02-07
Patient: 67 year old female
Adverse reactions / side effects: Renal Failure Acute
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Rosuvastatin Calcium; Risedronate Sodium; Furosemide; Lisinopril; Potassium Chloride; Aspirin; Atenolol; Celecoxib
Adverse event in 69 year old female receiving Zetia (Ezetimibe)
Reported by a individual with unspecified qualification from United Kingdom on 2007-01-29
Patient: 69 year old female
Adverse reactions / side effects: Rhabdomyolysis, Renal Failure Acute
Adverse event resulted in: death
Suspect drug(s):
Crestor
Dosage: 10mg frequency unknown; oral
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2004-01-01
Ibuprofen
Dosage: 400 mg 2x per 1 day; oral
Administration route: Oral
Indication: Osteoarthritis
Start date: 2006-04-05
Zetia
Dosage: 10mg frequency unknown; oral
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2004-01-01
Other drugs received by patient: Spironolactone; Cozaar Comp (Hydrochlorothiazide / Losartan Potassium); Metformin HCL; Rosiglitazone; Bisocard (Bisoprolol); Aspirin
Adverse event in 69 year old female receiving Zetia (Ezetimibe)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-01-22
Patient: 69 year old female
Adverse reactions / side effects: Rhabdomyolysis, Renal Failure Acute
Adverse event resulted in: death
Suspect drug(s):
Ibuprofen
Administration route: Oral
Indication: Osteoarthritis
Start date: 2006-04-05
Rosuvastatin Calcium
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2004-01-01
Zetia
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2004-01-01
Other drugs received by patient: Spironolactone; Hydrochlorothiazide and Losartan Potassium; Metformin; Rosiglitazone Maleate; Bisoprolol; Aspirin
|
